Spendlove Medical Researchinstitute
Logan, Utah
B+Health Score
72B+
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Good
💰
$2.2M
Total Revenue
📊
$15K
Total Expenses
🏦
$3.1M
Net Assets
📋
N/A
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
+1907.1%
Year-over-year change (2021 → 2022)
Net Margin
+99.3%
Revenue minus expenses as % of revenue
Filing History
12 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2022 | $2,178,002↑1907% | $15,179↓59% | $3,110,683↓2% | — |
| 2021 | $108,517↑235% | $37,429↑20% | $3,174,869↑2% | — |
| 2020 | $32,415↓47% | $31,097↑9% | $3,103,780 | — |
| 2019 | $61,531↓53% | $28,510↓94% | $3,099,450↑1% | — |
| 2018 | $130,967↑72% | $511,707↑3459% | $3,066,931↑122% | — |
| 2017 | $76,056↓42% | $14,376↓59% | $1,384,269↑5% | — |
| 2016 | $130,899↓74% | $35,059↓77% | $1,322,819↑8% | — |
| 2015 | $499,286↑1% | $153,759↓11% | $1,230,277↑39% | — |
| 2014 | $495,927↑10% | $172,182↓15% | $886,532↑58% | — |
| 2013 | $449,175↑3% | $202,668↓10% | $561,717↑36% | — |
| 2012 | $434,062↑37% | $225,370↑30% | $412,654↑14% | — |
| 2011 | $317,197 | $173,329 | $362,996 | — |
Frequently Asked Questions
What does Spendlove Medical Researchinstitute do?▼
Spendlove Medical Researchinstitute is a medical research nonprofit organization based in Utah. It is classified under NTEE code H99 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Spendlove Medical Researchinstitute financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Spendlove Medical Researchinstitute.
How much revenue does Spendlove Medical Researchinstitute generate?▼
Spendlove Medical Researchinstitute reports $2.2M in annual revenue and holds $3.1M in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in Utah.